USD 2.62
(-0.38%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 9.95 Million USD | -3.88% |
2022 | 10.35 Million USD | -39.02% |
2021 | 16.98 Million USD | 652.46% |
2020 | 2.25 Million USD | 19.42% |
2019 | 1.89 Million USD | 155.75% |
2018 | 739 Thousand USD | -17.34% |
2017 | 894 Thousand USD | -29.1% |
2016 | 1.26 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 9.77 Million USD | -5.86% |
2024 Q1 | 10.38 Million USD | 4.32% |
2023 Q4 | 9.95 Million USD | 0.08% |
2023 FY | 9.95 Million USD | -3.88% |
2023 Q3 | 9.94 Million USD | -5.24% |
2023 Q1 | 11 Million USD | 6.27% |
2023 Q2 | 10.49 Million USD | -4.62% |
2022 Q2 | 13.77 Million USD | -2.19% |
2022 Q3 | 11.23 Million USD | -18.42% |
2022 Q1 | 14.08 Million USD | -17.09% |
2022 FY | 10.35 Million USD | -39.02% |
2022 Q4 | 10.35 Million USD | -7.81% |
2021 Q4 | 16.98 Million USD | 243.72% |
2021 FY | 16.98 Million USD | 652.46% |
2021 Q3 | 4.94 Million USD | 20.22% |
2021 Q2 | 4.11 Million USD | 19.96% |
2021 Q1 | 3.42 Million USD | 51.79% |
2020 Q2 | 2.25 Million USD | 15.55% |
2020 Q1 | 1.95 Million USD | 3.44% |
2020 FY | 2.25 Million USD | 19.42% |
2020 Q4 | 2.25 Million USD | 2.4% |
2020 Q3 | 2.2 Million USD | -2.43% |
2019 Q4 | 1.89 Million USD | 16.02% |
2019 Q3 | 1.62 Million USD | -9.9% |
2019 FY | 1.89 Million USD | 155.75% |
2019 Q2 | 1.8 Million USD | 7.11% |
2019 Q1 | 1.68 Million USD | 128.42% |
2018 FY | 739 Thousand USD | -17.34% |
2018 Q3 | 1.15 Million USD | 0.0% |
2018 Q4 | 739 Thousand USD | -35.91% |
2018 Q1 | - USD | -100.0% |
2017 Q4 | 894 Thousand USD | 0.0% |
2017 FY | 894 Thousand USD | -29.1% |
2016 FY | 1.26 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Akoya Biosciences, Inc. | 180.36 Million USD | 94.481% |
AngioDynamics, Inc. | 317.67 Million USD | 96.866% |
AtriCure, Inc. | 613.93 Million USD | 98.378% |
Avinger, Inc. | 13.77 Million USD | 27.705% |
Azenta, Inc. | 2.88 Billion USD | 99.655% |
BioLife Solutions, Inc. | 412.71 Million USD | 97.588% |
The Cooper Companies, Inc. | 11.65 Billion USD | 99.915% |
Daxor Corporation | 34.86 Million USD | 71.45% |
Ekso Bionics Holdings, Inc. | 28.91 Million USD | 65.575% |
Femasys Inc. | 27.75 Million USD | 64.134% |
GlucoTrack, Inc. | 4.9 Million USD | -102.956% |
Harvard Bioscience, Inc. | 137.36 Million USD | 92.753% |
Hologic, Inc. | 9.15 Billion USD | 99.891% |
ICU Medical, Inc. | 4.37 Billion USD | 99.773% |
Intuitive Surgical, Inc. | 15.44 Billion USD | 99.936% |
KORU Medical Systems, Inc. | 28.46 Million USD | 65.022% |
LeMaitre Vascular, Inc. | 346.77 Million USD | 97.129% |
Innovative Eyewear, Inc. | 6.21 Million USD | -60.08% |
Innovative Eyewear, Inc. | 6.21 Million USD | -60.08% |
Masimo Corporation | 3.04 Billion USD | 99.673% |
Microbot Medical Inc. | 8.32 Million USD | -19.551% |
Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 94.209% |
Merit Medical Systems, Inc. | 2.32 Billion USD | 99.572% |
Nephros, Inc. | 11.86 Million USD | 16.069% |
NovoCure Limited | 1.14 Billion USD | 99.131% |
NEXGEL, Inc. | 9.95 Million USD | 0.0% |
Singular Genomics Systems, Inc. | 265.46 Million USD | 96.25% |
OraSure Technologies, Inc. | 482.84 Million USD | 97.938% |
Pro-Dex, Inc. | 54.21 Million USD | 81.636% |
Pulse Biosciences, Inc. | 60.8 Million USD | 83.628% |
Predictive Oncology Inc. | 14.41 Million USD | 30.951% |
Precision Optics Corporation, Inc. | 16.91 Million USD | 41.138% |
QuidelOrtho Corporation | 8.56 Billion USD | 99.884% |
Repligen Corporation | 2.82 Billion USD | 99.648% |
Sanara MedTech Inc. | 73.87 Million USD | 86.524% |
STAAR Surgical Company | 488.69 Million USD | 97.963% |
Sharps Technology, Inc. | 11.78 Million USD | 15.559% |
Utah Medical Products, Inc. | 135.45 Million USD | 92.651% |
DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.865% |
Jin Medical International Ltd. | 32.9 Million USD | 69.745% |